Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clevidipine Butyrate in Hypertensive Emergencies
NCT04670809Phase 3Unknown
- Sponsor
- Nanjing Yoko Biomedical Co., Ltd.
- Start
- Jul 2020
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clevidipine in hypertensive emergency, sponsored by Nanjing Yoko Biomedical Co., Ltd.. Status: unknown.
02
Drugs
clevidipine
03
Conditions
hypertensive emergency
Beyond the preview
Go deeper on NCT04670809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04670809.